Our finding that individuals with high levels of adiponectin have a different risk factor profile (less hypertension, diabetes, and obesity; older; and frail White women) and metabolomic profile supports the hypothesis that the pathogenesis may differ and thus the response to therapy may also differ. Here, ADIPOQ is linked to Obesity.